期刊文献+

基质金属蛋白酶-2及其抑制因子与心房颤动的相关性研究 被引量:3

Relationship between matrix metalloproteinases-2(MMP-2) and atrial fibrillation
下载PDF
导出
摘要 目的:探讨血清中基质金属蛋白酶-2(Matrix Metalloproteinases-2,MMP-2)及其抑制因子(Tissue inhibitor of metallop roteinase 2,TIMP-2)与心房颤动(房颤)患者心功能、左房内径的关系。方法:选择49例持续性(持续时间大于7d)房颤患者和47例窦性心律患者,分为房颤组和窦律组。采用ELISA测定两组血清MMP-2、TIMP-2水平,并用彩超测量两组患者左房内径的大小。结果:(1)房颤组血清MMP-2水平明显高于窦律组(P<0.05),且与左房内径大小呈直线正相关关系(r=0.345,P<0.05)。TIMP-2水平在房颤组与窦律组间无差异(P>0.05)。(2)房颤组患者左房内径水平明显高于窦律组(P<0.01)。结论:房颤组患者的MMP-2水平较窦律组高,且随心功能恶化而升高,可能是导致持续性房颤患者左心房内径扩大的原因之一。 Objiective:To investigate the relationship between matrix metalloproteinases-2(MMP-2) and atrial fibrillation,also to investigate the relationship between MMP-2,cardiac function and left atria diameter of patients with atrial fibrillation.Methods:49 patients with persistent atrial fibrillation were included in the atrial fibrillation groups,and 47 patients with sinus rhythm were selected in the control group,the serum concentration of MMP-2 and TIMP-2 were measured with ELISA.The size of left atria diameter were detected with Doppler Ultrasonic cardiogram.Results:(1) The level of MMP-2 in atrial fibrillation group was significantly higher than that in control group(P0.05),there was a positive correlation between left atria diameter and serum MMP-2 levels in the atrial fibrillation group(r=0.345,P0.05).The level of the serum TIMP-2 showed no difference between the atrial fibrillation group and the control group(P0.05).(2) The size of left atria diameter in atrial fibrillation group was significant higher than that in the control group(P0.01).Conclusions:The levels of serum MMP-2 increased in patients with persistent atrial fibrillation,both rose with severity of chronic heart failure.Rising of MMP-2 levels is one of the reason that left atria enlarged in persistent atrial fibrillation.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第3期439-441,共3页 Journal of Chongqing Medical University
关键词 心房颤动 基质金属蛋白酶 Atrial fibrillation Matrix metalloproteinase
  • 相关文献

参考文献7

  • 1Xu J,Cui G,Esmailian F,et al.Atrial extracellularmatrix remodeling and the maintenance of atrial fibrillation[J].Circulation,2004,109(3):363-368.
  • 2Hemandez-Barrantes S,Toth M,Bemardo M M,et al.Binding of active(57 kD) membrane type 1-matrix metalloproteinase (MTl-MMP) to tissue inhibitor of metalloptroteinase (TIMP)-2 regulates MTI-MMP processing and pro-MMP-2 activation[J].Biol Chem,2000,12080-12089.
  • 3Ke D,Xu C X,Zhang J C,et al.Changes in gelatinases expression and activity in human atrial during atrial fibrillation[J].Chin J Cardiol,2005,33(2):137-142.
  • 4Ke D,Xu C X,Zhang J C,et al.Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation[J].Chin J Cardiol,2005,33(4):459-462.
  • 5Li H,Sinon H,Bocan T M,et al.MMP/TIMP expression in spontaneously hypertensive heart failure rats:the effect of ACE-and MMP-inhibition[J].Cardiovasc RES,2000,46:298-306.
  • 6Spinale F G,Coker M L,Heung L J,et al.A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure[J].Circulation,2000,102(16):1944-1949.
  • 7Yanfen S,Anique D,Danshi L,et,al.Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation[J].Cardiovascular Research,2001,52:217-225.

同被引文献25

  • 1朱慧,张薇,郭辰虹,张供,张维东,钟明,杨贵荣,葛志明,张运.心房肌基质金属蛋白酶-9和组织金属蛋白酶抑制因子-1表达改变对房颤心房重构机制的研究[J].中华医学杂志,2005,85(1):45-48. 被引量:30
  • 2柯丹,许春萱,张建成,陈林,林亚洲,林立芳,胡锡衷.心房颤动患者心房组织中明胶酶的基因表达及活性变化[J].中华心血管病杂志,2005,33(2):137-142. 被引量:26
  • 3柯丹,许春萱,林亚洲,张建成,陈林,林立芳,胡锡衷.心房颤动患者心房纤维化分子基础的临床研究[J].中华心血管病杂志,2005,33(5):459-463. 被引量:25
  • 4Kamel H,Lees KR, Lyden PD, et al. Delayed detection of atrial fibrillation after ischemic stroke[J]. J Stroke Cere- brovasc Dis, 2009,18(6) .. 453-457.
  • 5Van Gelder IC, EHRA Education Committee, Boriani G, et al. Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation[J]. Europace, 2008,10 (1) : 77-78,124.
  • 6Vivanco Hidalgo RM,Rodriguez Campello A,Ois Santia- go A, et al. Cardiac monitoring in stroke units:importance of diagnosing atrial fibrillation in acute isehemic stroke [J]. Rev Esp Cardiol,2009,62(5) :564-567.
  • 7Schnabel RB, Larson MG, Yamamoto JF, et al. Relation of multiple inflammatory biomarkers to incident atrial fibril- lation[J]. Am J Cardiol,2009,104(1) :92-96.
  • 8Min J, Farooq MU, Greenberg E, et al. Cardiac dysfunc- tion after left permanent cerebral focal ischemia:the brain and heart connection[J]. Stroke, 2009,40 (7) : 2560-2563.
  • 9Frontera JA,Parra A,Shimbo D,et al. Cardiac arrhythmi- as after subarachnoid hemorrhage:risk factors and impact on outcome[J]. Cerebrovasc Dis, 2008,26 (1) : 71-78.
  • 10Li SB,Yang F,Jing L,et al.Myeloperox idase and risk ofrecurrence of atrial fibrillation after catheter ablation[J].JInvestig Med,2013,61(4):722-727.

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部